A Noncanonical, GSK3-Independent Pathway Controls Postprandial Hepatic Glycogen Deposition
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Summary Insulin rapidly suppresses hepatic glucose production and slowly decreases expression of genes encoding gluconeogenic proteins. In this study, we show that an immediate effect of insulin is to redirect newly synthesized glucose-6-phosphate to glycogen without changing the rate of gluconeogenesis. This process requires hepatic Akt2, as revealed by blunted insulin-mediated suppression of glycogenolysis in the perfused mouse liver, elevated hepatic glucose production during a euglycemic-hyperinsulinemic clamp, or as diminished glycogen accumulation during clamp or re-feeding in mice without hepatic Akt2. Surprisingly, the absence of Akt2 disrupted glycogen metabolism independent of GSK3α/β phosphorylation, which is thought to be an essential step in the pathway by which insulin is regulates glycogen synthesis through Akt. These data show that 1) the immediate action of insulin to suppress hepatic glucose production functions via an Akt2-dependent redirection of glucose-6-phosphate to glycogen and 2) insulin increases glucose phosphorylation and conversion to glycogen independent of GSK3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.055 · Cited by 1,377
Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis
McManus, E. J., Sakamoto, K., Armit, L. J., Ronaldson, L., Shpiro, N., Marquez, R., & Alessi, D. R. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600633 · Cited by 594 · cited 6×
“Animals The Akt2 / , Akt2(lox/lox); AFP > CRE, and GSK3aS21A/S21A;bS9A/S9A mice have been described previously (Cho et al., 2001; Leavens et al., 2009; McManus et al., 2005).”
InfluentialSelf-citationQuantitation of Hepatic Glycogenolysis And Gluconeogenesis in Fasting Humans With 13 C NMR
Rothman, D. L., Magnusson, I., Katz, L. D., Shulman, R. G., & Shulman, G. I. (1991) · Science · doi:10.1126/science.1948033 · Cited by 546 · cited 1×
“In humans, who have residual hepatic glycogen after an overnight fast, feeding both stimulates glycogen synthesis and suppresses glycogenolysis (Rothman et al., 1991; Taylor et al., 1996).”
Hormonal regulation of hepatic glucose production in health and disease
Lin, H. V., & Accili, D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.003 · Cited by 429
Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes.
Krssak, M., Brehm, A., Bernroider, E., Anderwald, C., Nowotny, P., Man, C. D., Cobelli, C., Cline, G. W., Shulman, G. I., Waldhäusl, W., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3048 · Cited by 313 · cited 1×
“Since insulin’s major role is to redirect glucose to glycogen, it stands to reason that the primary defect in Akt2(lox/lox); AFP > CREmice would be in this process, which is also dysfunctional in human insulin-resistant states (Krssak et al., 2004).”
Taylor, R., Magnusson, I., Rothman, D. L., Cline, G. W., Caumo, A., Cobelli, C., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118379 · Cited by 258 · cited 1×
“In humans, who have residual hepatic glycogen after an overnight fast, feeding both stimulates glycogen synthesis and suppresses glycogenolysis (Rothman et al., 1991; Taylor et al., 1996).”
Allosteric Regulation of Glycogen Synthase Controls Glycogen Synthesis in Muscle
Bouskila, M., Hunter, R. W., Ibrahim, A. F. M., Delattre, L., Peggie, M., van Diepen, J. A., Voshol, P. J., Jensen, J., & Sakamoto, K. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.10.006 · Cited by 196
Self-citationCohen, P. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0399 · Cited by 158 · cited 1×
“A well-defined pathway has been established by which insulin is thought to promote deposition of glycogen (Cohen, 1999).”
Cited by
AKT/PKB Signaling: Navigating the Network
Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772
The PI3K/AKT Pathway in Obesity and Type 2 Diabetes
Huang, X., Liu, G., Guo, J., & Su, Z. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.27173 · Cited by 1,673
“[161] C57BL/6 mice HepG2 cell glycerol kinase (Gyk) Decreases the expression of FoxO1 reduced expression of G6Pase and PEPCK [162] C57BL/6 mice NPC1L1 Regulates the AKT-FOXO1-PEPCK/G6Pase pathway reduced expression of G6Pase and PEPCK [163] MCF7-tet OFF Sesn2F cells Sestrins (Sesn1/2/3) through activation of AMPK and…”
BackgroundInfluentialThe pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Samuel, V. T., & Shulman, G. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci77812 · Cited by 1,484
“Recent studies challenge the primacy of the Akt/GSK3β/ glycogen synthase branch in the regulation of glycogen synthesis (10).”
BackgroundInfluentialThe integrative biology of type 2 diabetes
Roden, M., & Shulman, G. I. (2019) · Nature · doi:10.1038/s41586-019-1797-8 · Cited by 1,167
Regulation of hepatic glucose metabolism in health and disease
Petersen, M. C., Vatner, D. F., & Shulman, G. I. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.80 · Cited by 1,133
Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases
Samuel, V. T., & Shulman, G. I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.002 · Cited by 745
“This acute and direct action of insulin may be more focused on Akt2-mediated regulation of hepatic glycogen metabolism (Wan et al., 2013).”
Insulin signaling in health and disease
Saltiel, A. R. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142241 · Cited by 446
“GSK3 inhibition is not sufficient for full activation of glycogen, since GSK3 does not phosphorylate all of the residues of glycogen synthase that are dephosphorylated in response to insulin (157), and knockins of GSK3 mutants have failed to support this enzyme’s role in stimulating glycogen synthesis (158, 159).”
BackgroundUnraveling the Regulation of Hepatic Metabolism by Insulin
Titchenell, P. M., Lazar, M. A., & Birnbaum, M. J. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.03.003 · Cited by 437
Self-citationSignaling pathways in obesity: mechanisms and therapeutic interventions
Wen, X., Zhang, B., Wu, B., Xiao, H., Li, Z., Li, R., Xu, X., & Li, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01149-x · Cited by 410
Resolving the paradox of hepatic insulin resistance
Santoleri, D., & Titchenell, P. M. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.10.016 · Cited by 336
Bo, T., Gao, L., Yao, Z., Shao, S., Wang, X., Proud, C. G., & Zhao, J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.006 · Cited by 293
Titchenell, P. M., Quinn, W. J., Lu, M., Chu, Q., Lu, W., Li, C., Chen, H., Monks, B. R., Chen, J., Rabinowitz, J. D., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.022 · Cited by 281
Self-citationHepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo
Titchenell, P. M., Chu, Q., Monks, B. R., & Birnbaum, M. J. (2015) · Nature Communications · doi:10.1038/ncomms8078 · Cited by 169
Self-citationThe LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver
Patel, K., Foretz, M., Marion, A., Campbell, D. G., Gourlay, R., Boudaba, N., Tournier, E., Titchenell, P., Peggie, M., Deak, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms5535 · Cited by 161
Self-citationKowalski, G. M., & Bruce, C. R. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00165.2014 · Cited by 154
“However, changes in gluconeogenic gene/protein expression often do not correlate with alterations in gluconeogenesis or EGP, particularly in vivo (14, 34, 41, 58, 60, 69, 103, 114, 138, 141, 142, 156, 176).”
BackgroundHonka, M.-J., Latva-Rasku, A., Bucci, M., Virtanen, K. A., Hannukainen, J. C., Kalliokoski, K. K., & Nuutila, P. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0882 · Cited by 140
Liver-specific deletion of Ppp2cα enhances glucose metabolism and insulin sensitivity
Xian, L., Hou, S., Huang, Z., Tang, A., Shi, P., Wang, Q., Song, A., Jiang, S., Lin, Z., Guo, S., et al. (2015) · Aging · doi:10.18632/aging.100725 · Cited by 31
“Bouskila M, Hirshman MF, Jensen J, Goodyear LJ and Sakamoto K. Insulin promotes glycogen synthesis in the absence of GSK3 phosphorylation in skeletal muscle.”
BackgroundInfluentialHepatocyte β‐catenin loss is compensated by Insulin‐mTORC1 activation to promote liver regeneration
Hu, S., Cao, C., Poddar, M., Delgado, E., Singh, S., Singh‐Varma, A., Stolz, D. B., Bell, A., & Monga, S. P. (2023) · Hepatology · doi:10.1002/hep.32680 · Cited by 11
Metadata
- Authors
- Wan, M., Leavens, K. F., Hunter, R. W., Koren, S., von Wilamowitz-Moellendorff, A., Lu, M., Satapati, S., Chu, Q., Sakamoto, K., Burgess, S. C., & Birnbaum, M. J.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 18
- Issue
- 1
- Pages
- 99-105
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2121871861
- Cited by
- 79
- References
- 8
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.